Calquence 100 mg, Hartkapseln

7680677900013 CH-67790 Kapseln

Associated product:

CALQUENCE caps 100 mg 60 pce
Calquence 100 mg, Hartkapseln
Calquence 100 mg, Hartkapseln
Calquence 100 mg, Hartkapseln
1 / 3
google

Article details

Package size
60
Selling units
60
Measure
Kapsel(n)
Galenic form
Kapseln
Galenic group
Tabletten

Official Swissmedic V2 data

Additional information from the official database

Detailed composition

Substance Quantity Type Category
acalabrutinibum
100.0 MG Substance Wirkstoff (Principe actif)
cellulosum microcristallinum silicificatum
- Substance HNIDK
amylum pregelificatum
- Substance HNIDK
carboxymethylamylum natricum A
- Substance HNIDK
natrium
- Substance HBESI
magnesii stearas
- Substance HNIDK
gelatina
- Substance HNIDK
E 172 (flavum)
- Substance FTODK
E 132
- Substance FIMDK
E 171
- Substance FNIDK
lacca
- Substance HNIDK
E 172 (nigrum)
- Substance FTODK
propylenglycolum
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)
ammonii hydroxidum
- Substance HNIDK

Authorization holder

AstraZeneca AG

6340 Baar

Authorization information

Swissmedic authorization number
67790
Drug name
Calquence, Hartkapseln
Galenic form
KAHA
ATC Code
L01EL02
Authorization status
Revoked/Withdrawn
Dispensing category
A
First authorization
04/03/2021
Authorization expiration date
03/03/2026
IT Number
07.16.1.
Domain
Human medicine
Field of application
chronisch lymphatische Leukämie (CLL)

Package details

Description (FR)
CALQUENCE caps 100 mg 60 pce
Description (DE)
CALQUENCE Kaps 100 mg 60 Stk
Market launch
04/03/2021
Market withdrawal
02/06/2026
Narcotic (BTM)
No
Buy us a coffee Explore the data